Medical devices, healthcare technology and the business of care
PMA approval · P240027

SpineSeal Spine Sealant

Pramand, LLC · Decision date Feb 14, 2025

FDA DECISIONP240027

What did the FDA approve?

FDA records P240027 as an original PMA application. The recorded decision is approval, dated Feb 14, 2025.

FDA approval order statement

The SpineSeal Spine Sealant is indicated for use as an adjunct to sutured dural repair during spinal surgery to provide watertight closure.
Regulatory pathway
Original PMA
Clinical specialty
Neurology
Decision date
Feb 14, 2025

FDA source record

Regulatory record facts

Identifier
P240027
Regulatory pathway
Premarket approval application
Applicant
Pramand, LLC
Product code
NQR
Decision code
APPR
Decision date
Feb 14, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Sealant, dural.

Applicant
Pramand, LLC
Product code
NQR
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P240027 received

    Application receipt date recorded by FDA.

  2. P240027 · FDA decision

    APPR

  3. P240027/S007 · Related supplement

    SpineSeal Spine Sealant

Timeline entries are records held by MedtechLedger for P240027. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240027

Product / regulatory recordCompanyPathwayDecision dateSource
Pramand, LLCPMA supplementSep 11, 2026FDA

Explore the linked device profile

Other records with product code NQR

Product / regulatory recordCompanyPathwayDecision dateSource
Pramand, LLCPMA supplementOct 1, 2026FDA
Pramand, LLCPMA approvalJul 6, 2023FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Pramand, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
201 Burlington Rd., Suite 210, Bedford, MA, 02420

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records